Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
Related Questions
How do you decide on treatment modality for ocular surface squamous neoplasia?
What strategies do you use to optimize cataract surgery outcomes in patients with anterior basement membrane dystrophy (ABMD)?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How does CTAK compare to conventional keratoplasty techniques (PK/ALK) in patients with corneal ectasia?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
How do you approach the use of Cequa in eyes with severe corneal thinning from a prior, healed corneal ulcer?
Which IOL do you prefer for patients with a history of hyperopic LASIK to minimize the risk of inducing spherical aberration?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What supportive care measures do you prioritize to manage or prevent toxicity in patients receiving Dato-DXd?
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
